Overview

Safety and Efficacy of Ustekinumab in Patients With Palmo-Plantar Pustular Psoriasis or With Palmo-Plantar Pustulosis

Status:
Terminated
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study will provide data on sasety and efficacy of Ustekinumab in patients suffering from Palmo-Plantar Pustular Psoriasis (PPPP) or Palmo-Plantar Pustulosis(PPP)
Phase:
Phase 3
Details
Lead Sponsor:
Innovaderm Research Inc.
Collaborator:
Janssen-Ortho LLC
Treatments:
Ustekinumab